1. at receptor antagonists D (3) Shock 口 cardiac output↑; d redistribution of blood flow. D shift of fluid from interstitial compartment to vascular compartment; 口 pulmonary pressure↓; u fully adequate replacement of intravascular fluid
(3) Shock cardiac output ; redistribution of blood flow; shift of fluid from interstitial compartment to vascular compartment; pulmonary pressure ; fully adequate replacement of intravascular fluid 1. receptor antagonists
1. at receptor antagonists D (4) Acute myocardial infarction and congestive heart failure after -load v 口 cardiac output个 a (5)Pheochromocytoma I pre-and post-operation 口 diagnosis I (6) Others: impotency
(4) Acute myocardial infarction and congestive heart failure after-load cardiac output (5) Pheochromocytoma pre- and post-operation diagnosis (6) Others: impotency 1. receptor antagonists
1. at receptor antagonists 口1.3 Adverse effects I ()Postural hypotension D(2) Reflex heart stimulation D tachycardia, arrhythmia, angina pectoris 口3) GI reactions u(4Other central depression
1.3 Adverse effects (1) Postural hypotension (2) Reflex heart stimulation tachycardia, arrhythmia, angina pectoris (3) GI reactions (4) Other central depression 1. receptor antagonists
1. at receptor antagonists 口T0 lazoline妥拉唑啉 weak effects more severe adverse effects
Tolazoline 妥拉唑啉 weak effects more severe adverse effects 1. receptor antagonists
1. at receptor antagonists Long-acting Phenoxybenzamin酚羊明」 Longer action duration used for peripheral vasculardiseases anti-shock 口口口 pheochromocytoma improving urinary flow in patients with benign prostatic hypertrophy
Long-acting Longer action duration used for peripheral vasculardiseases anti-shock pheochromocytoma improving urinary flow in patients with benign prostatic hypertrophy Phenoxybenzamine 酚苄明 1. receptor antagonists